Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
Quickflows
243.58 +0.37  +0.15% NYSE Jul 27, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All LLY News

News

View All Events

Events

Date Type Description
08/12/2021 Dividends 0.85 Normal dividend, declared June 29, 2021 and paid September 10, 2021
08/03/2021 Earnings Results Q2 2021 Earnings Results
08/03/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
05/13/2021 Dividends 0.85 Normal dividend, declared May 03, 2021 and paid June 10, 2021
04/27/2021 Earnings Results Q1 2021 Earnings Results
04/27/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
02/11/2021 Dividends 0.85 Normal dividend, declared December 14, 2020 and paid March 10, 2021
01/29/2021 Earnings Results Q4 2020 Earnings Results
01/29/2021 09:00 EST Earnings Calls Q4 2020 Earnings Call
11/12/2020 Dividends 0.74 Normal dividend, declared October 19, 2020 and paid December 10, 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 25.49B
Total Expenses (TTM) 18.67B
Net Income (TTM) 6.092B

Balance Sheet View Statement

Total Assets (Quarterly) 46.84B
Total Liabilities (Quarterly) 39.74B
Shareholders Equity (Quarterly) 6.899B

Cash Flow Statement View Statement

Cash from Operations (TTM) 7.815B
Cash from Investing (TTM) -2.482B
Cash from Financing (TTM) -4.302B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
  • URL: https://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Aug. 03, 2021
  • Last Earnings Release: Apr. 27, 2021
  • Next Ex-Dividend Date: Aug. 12, 2021
  • Last Ex-Dividend Date: May. 13, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 243.58
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VPMCX Vanguard PRIMECAP Inv 5.04%
VGHCX Vanguard Health Care Inv 4.44%
VHCOX Vanguard Capital Opportunity Inv 4.27%
XLV Health Care Select Sector SPDR® ETF 3.89%
VHT Vanguard Health Care ETF 3.17%
USMV iShares MSCI USA Min Vol Factor ETF 1.68%
VYM Vanguard High Dividend Yield ETF 1.47%
RRGSX T. Rowe Price Growth Stock R 1.24%
VIVAX Vanguard Value Index Inv 1.19%
VTV Vanguard Value ETF 1.19%
FCNKX Fidelity® Contrafund® K 0.89%
IWF iShares Russell 1000 Growth ETF 0.74%

Comparables

Edit
REGN Regeneron Pharmaceuticals Inc
BIIB Biogen Inc
JNJ Johnson & Johnson
MRK Merck & Co Inc
PFE Pfizer Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.